The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Molecular Pathogenesis of Alzheimer's Disease: An Update
Open accessAbstract
Dementia is a chronic or progressive syndrome, characterized by impaired cognitive capacity beyond what could be considered a consequence of normal aging. It affects the memory, thinking process, orientation, comprehension, calculation, learning ability, language, and judgment; although awareness is usually unaffected. Alzheimer's disease (AD) is the most common form of dementia; symptoms include memory loss, difficulty solving problems, disorientation in time and space, among others. The disease was first described in 1906 at a conference in Tubingen, Germany by Alois Alzheimer. One hundred and ten years since its first documentation, many aspects of the pathophysiology of AD have been discovered and understood, however gaps of knowledge continue to exist. This literature review summarizes the main underlying neurobiological mechanisms in AD, including the theory with emphasis on amyloid peptide, cholinergic hypothesis, glutamatergic neurotransmission, the role of tau protein, and the involvement of oxidative stress and calcium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,098
Long-Term Potentiation and Memory
LYNCH, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00014.2003 · Cited by 1,991
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Dong, X.-X., Wang, Y., & Qin, Z.-H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.24 · Cited by 1,297
Terry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041616 · Cited by 1,159
Boland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119
Alzheimer's disease: strategies for disease modification
Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,064
Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965
Mechanism of Oxidative Stress in Neurodegeneration
Gandhi, S., & Abramov, A. Y. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/428010 · Cited by 960
Arispe, N., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 926
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855
Autophagy, amyloidogenesis and Alzheimer disease
Nixon, R. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.019265 · Cited by 749
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740
The mitochondrial energy transduction system and the aging process
Navarro, A., & Boveris, A. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00213.2006 · Cited by 646
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 637
Presynaptic inhibition of elicited neurotransmitter release
Wu, L.-G., & Saggau, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01015-6 · Cited by 627
Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal
Praticò, D. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.09.001 · Cited by 606
Deane, R., Bell, R., Sagare, A., & Zlokovic, B. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601867 · Cited by 548
The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam, M. (2004) · Learning & Memory · doi:10.1101/lm.69204 · Cited by 467
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
Tau phosphorylation: physiological and pathological consequences
Stoothoff, W. H., & Johnson, G. V. W. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.017 · Cited by 442
Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., & Zhang, Y.-W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608856200 · Cited by 436
M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice
Caccamo, A., Oddo, S., Billings, L. M., Green, K. N., Martinez-Coria, H., Fisher, A., & LaFerla, F. M. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.020 · Cited by 417
N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
FAN, M., & RAYMOND, L. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.003 · Cited by 413
Generation of superoxide by the mitochondrial Complex I
Grivennikova, V. G., & Vinogradov, A. D. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.03.013 · Cited by 379
Zheng, W.-H., Bastianetto, S., Mennicken, F., Ma, W., & Kar, S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00404-9 · Cited by 321
Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Cummings, J. L., Doody, R., & Clark, C. (2007) · Neurology · doi:10.1212/01.wnl.0000295996.54210.69 · Cited by 279
Stutzmann, G. E., Caccamo, A., LaFerla, F. M., & Parker, I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4386-03.2004 · Cited by 278
Neurobiology of Alzheimer′s disease
Mohandas, E., Rajmohan, V, & Raghunath, B. (2009) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.44908 · Cited by 268
The Glutamatergic System and Alzheimer???s Disease: Therapeutic Implications
Butterfield, D. A., & Pocernich, C. B. (2003) · CNS Drugs · doi:10.2165/00023210-200317090-00004 · Cited by 267
Szado, T., Vanderheyden, V., Parys, J. B., De Smedt, H., Rietdorf, K., Kotelevets, L., Chastre, E., Khan, F., Landegren, U., Söderberg, O., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711324105 · Cited by 262
Mitochondrial intermembrane junctional complexes and their involvement in cell death
Crompton, M., Barksby, E., Johnson, N., & Capano, M. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01368-8 · Cited by 258
Models of β-amyloid induced Tau-pathology: The long and “folded” road to understand the mechanism
Stancu, I.-C., Vasconcelos, B., Terwel, D., & Dewachter, I. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-51 · Cited by 256
Velliquette, R. A., O'Connor, T., & Vassar, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2350-05.2005 · Cited by 254
Grbovic, O. M., Mathews, P. M., Jiang, Y., Schmidt, S. D., Dinakar, R., Summers-Terio, N. B., Ceresa, B. P., Nixon, R. A., & Cataldo, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304122200 · Cited by 236
Amyloid beta peptides and glutamatergic synaptic dysregulation
Parameshwaran, K., Dhanasekaran, M., & Suppiramaniam, V. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.008 · Cited by 235
Inflammation, anti-inflammatory agents and Alzheimer disease: The last 12 years
McGeer, P. L., Rogers, J., & McGeer, E. G. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s330 · Cited by 227
RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease
Yan, S., Chen, X., Walker, D., Schmidt, A., Arancio, O., & Lue, L.-F. (2007) · Current Molecular Medicine · doi:10.2174/156652407783220741 · Cited by 207
Brain Imaging of Nicotinic Receptors in Alzheimer's Disease
Wu, J., Ishikawa, M., Zhang, J., & Hashimoto, K. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/548913 · Cited by 205
Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 202
Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease
Zhu, X., Perry, G., Moreira, P. I., Aliev, G., Cash, A. D., Hirai, K., & Smith, M. A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9207 · Cited by 196
Tau protein, the paired helical filament and Alzheimer's disease
Goedert, M., Klug, A., & Crowther, R. A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s323 · Cited by 194
Sennvik, K., Fastbom, J., Blomberg, M., Wahlund, L.-O., Winblad, B., & Benedikz, E. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00929-5 · Cited by 193
Bourne, K. Z., Ferrari, D. C., Lange‐Dohna, C., Roßner, S., Wood, T. G., & Perez‐Polo, J. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21252 · Cited by 188
Increased β-secretase activity and expression in rats following transient cerebral ischemia
Wen, Y., Onyewuchi, O., Yang, S., Liu, R., & Simpkins, J. W. (2004) · Brain Research · doi:10.1016/j.brainres.2003.09.086 · Cited by 188
Recent developments in Alzheimer's disease therapeutics
Rafii, M. S., & Aisen, P. S. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-7 · Cited by 187
α7 Nicotinic Acetylcholine Receptors Mediate β-Amyloid Peptide-induced Tau Protein Phosphorylation
Wang, H.-Y., Li, W., Benedetti, N. J., & Lee, D. H. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212532200 · Cited by 185
β‐Amyloid Degradation and Alzheimer′s Disease
Wang, D.-S., Dickson, D. W., & Malter, J. S. (2006) · BioMed Research International · doi:10.1155/jbb/2006/58406 · Cited by 185
Cyclophilin D in mitochondrial pathophysiology
Giorgio, V., Soriano, M. E., Basso, E., Bisetto, E., Lippe, G., Forte, M. A., & Bernardi, P. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.12.006 · Cited by 180
Glutamate–glutamine cycling in Alzheimer's disease
WALTON, H., & DODD, P. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.10.007 · Cited by 174
Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans
Ellis, J. R., Ellis, K. A., Bartholomeusz, C. F., Harrison, B. J., Wesnes, K. A., Erskine, F. F., Vitetta, L., & Nathan, P. J. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005407 · Cited by 155
Intracellular Calcium Dysregulation: Implications for Alzheimer’s Disease
Magi, S., Castaldo, P., Macrì, M. L., Maiolino, M., Matteucci, A., Bastioli, G., Gratteri, S., Amoroso, S., & Lariccia, V. (2016) · BioMed Research International · doi:10.1155/2016/6701324 · Cited by 151
Na-K-Cl Cotransporter Contributes to Glutamate-Mediated Excitotoxicity
Beck, J., Lenart, B. A., Kintner, D. B., & Sun, D. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05061.2003 · Cited by 148
Non-Cholinergic Strategies for Treating and Preventing Alzheimer??s Disease
Doraiswamy, P. M. (2002) · CNS Drugs · doi:10.2165/00023210-200216120-00003 · Cited by 142
Cell “Self‐Eating” (Autophagy) Mechanism in Alzheimer's Disease
Funderburk, S. F., Marcellino, B. K., & Yue, Z. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20161 · Cited by 139
Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk, G. L. (2006) · PubMed · Cited by 134
Miners, J. S., Baig, S., Tayler, H. M., Kehoe, P. G., & Love, S. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181afe475 · Cited by 130
Pasternak, S., Callahan, J. W., & Mahuran, D. J. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6107 · Cited by 128
Evaluating triggers and enhancers of tau fibrillization
Kuret, J., Congdon, E. E., Li, G., Yin, H., Yu, X., & Zhong, Q. (2005) · Microscopy Research and Technique · doi:10.1002/jemt.20187 · Cited by 119
ESCRT functions in autophagy and associated disease
Rusten, T. E., & Simonsen, A. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5784 · Cited by 118
Махаева, Г. Ф., Lushchekina, S. V., Boltneva, N. P., Sokolov, V. B., Grigoriev, V. V., Serebryakova, O. G., Vikhareva, E. A., Aksinenko, A. Y., Barreto, G. E., Aliev, G., et al. (2015) · Scientific Reports · doi:10.1038/srep13164 · Cited by 105
Schaeffer, E. L., & Gattaz, W. F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1092-0 · Cited by 99
Dysregulation of Calcium Homeostasis in Alzheimer’s Disease
Small, D. H. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9960-5 · Cited by 96
Bacopa monniera Attenuates Scopolamine‐Induced Impairment of Spatial Memory in Mice
Saraf, M. K., Prabhakar, S. K., KHANDUJA, K. L., & Anand, A. (2010) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/neq038 · Cited by 92
Geerts, H., & Grossberg, G. T. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006288734 · Cited by 90
Lichtenthaler, S. F., & Haass, C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21746 · Cited by 88
Fisher, A. (2008) · Neurodegenerative Diseases · doi:10.1159/000113712 · Cited by 87
Current and Emerging Pharmacological Treatment Options for Dementia
Ringman, J. M., & Cummings, J. L. (2006) · Behavioural Neurology · doi:10.1155/2006/315386 · Cited by 86
Ni, R., Marutle, A., & Nordberg, A. K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121447 · Cited by 85
Role of Calcium in the Pathogenesis of Alzheimer’s Disease and Transgenic Models
Green, K. N., Smith, I. F., & LaFerla, F. M. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_19 · Cited by 79
Allosteric Modulation of PS1/γ-Secretase Conformation Correlates with Amyloid β42/40 Ratio
Uemura, K., Lill, C. M., Li, X., Peters, J. A., Ivanov, A., Fan, Z., Strooper, B. D., Bacskai, B. J., Hyman, B. T., & Berezovska, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007893 · Cited by 78
Liskowsky, W., & Schliebs, R. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.010 · Cited by 73
Nicotinic Cholinergic Mechanisms in Alzheimer's Disease
Shen, J., & Wu, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.08.002 · Cited by 70
Lin, H., Vicini, S., Hsu, F., Doshi, S., Takano, H., Coulter, D. A., & Lynch, D. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007397107 · Cited by 68
Role of N-methyl-D-aspartate receptors in polychlorinated biphenyl mediated neurotoxicity
Ndountse, L. T., & Chan, H. M. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.10.013 · Cited by 65
Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease
Helmfors, L., Boman, A., Civitelli, L., Nath, S., Sandin, L., Janefjord, C., McCann, H., Zetterberg, H., Blennow, K., Halliday, G. M., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.024 · Cited by 64
Alzheimer's disease therapeutic research: the path forward
Aisen, P. S. S. (2009) · Alzheimer s Research & Therapy · doi:10.1186/alzrt2 · Cited by 60
The Role of β-Amyloid Protein in Synaptic Function: Implications for Alzheimers Disease Therapy
Peña‐Ortega, F., Gutiérrez-Lerma, A. I., Quiroz‐Baez, R., & Arias, C. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359531 · Cited by 56
CALCIUM: A Role for Neuroproduction and Sustained Adaptation
Friedman, L. K. (2006) · Molecular Interventions · doi:10.1124/mi.6.6.5 · Cited by 52
M1 Muscarinic Agonists Target Major Hallmarks of Alzheimers Disease – an Update
Fisher, A. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018163 · Cited by 51
Exploring the Vertebrate Central Cholinergic Nervous System
Karczmar, A. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-46526-5 · Cited by 48
Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition
Jung, K., Chu, K., Lee, S., Park, H.-K., Kim, J.-H., Kang, K., Kim, M., Lee, S. K., & Roh, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.081 · Cited by 48
Treatment of dementia with neurotransmission modulation
Doggrell, S. A., & Evans, S. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.10.1633 · Cited by 48
Saraf, M. K., Anand, A., & Prabhakar, S. (2010) · Neurochemical Research · doi:10.1007/s11064-009-0051-4 · Cited by 48
Amyloid-β pathology induced in humans
Jucker, M., & Walker, L. C. (2015) · Nature · doi:10.1038/525193a · Cited by 47
2-Aminoethoxydiphenyl-borate (2-APB) increases excitability in pyramidal neurons
Hagenston, A. M., Rudnick, N. D., Boone, C. E., & Yeckel, M. F. (2008) · Cell Calcium · doi:10.1016/j.ceca.2008.11.003 · Cited by 41
Medial septal dysfunction by Aβ-induced KCNQ channel-block in glutamatergic neurons
Leão, R. N., Colom, L. V., Borgius, L., Kiehn, O., & Fisahn, A. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.013 · Cited by 38
Calcium and Neurogenesis in Alzheimer's Disease
Wang, J. M., & Sun, C. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00194 · Cited by 31
Neurobiology of Alzheimer's Disease
Masters, C. L. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)80030-0 · Cited by 26
Li, Y., Xing, Y., Shen, Y., Zhao, J., Yue, R., Liu, F., He, W., Wang, R., Shan, L., & Zhang, W. (2016) · Aging · doi:10.18632/aging.100913 · Cited by 21
Disruption of Calcium Homeostasis in Alzheimer’s Disease
Korol’, T. Y., Korol, S. V., Kostyuk, E. P., & Kostyuk, P. G. (2008) · Neurophysiology · doi:10.1007/s11062-009-9064-5 · Cited by 18
Enfermedad de Alzheimer: Actualización en terapia farmacológica
Patricio Fuentes, G., & Slachevsky, A. (2005) · Revista médica de Chile · doi:10.4067/s0034-98872005000200012 · Cited by 12
PEN-2 Overexpression Induces γ-Secretase Protein and its Activity with Amyloid β-42 Production
Seo, S. J., Hwang, D. Y., Cho, J. S., Chae, K. R., Kim, C. K., Shim, S. B., Jee, S. W., Lee, S. H., Sin, J. S., Choi, S. Y., et al. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9262-0 · Cited by 8
Links Between Amyloid and Tau Biology in Alzheimer’s Disease and Their Cholinergic Aspects
Siegel, G. J., Chauhan, N. B., & Karczma, A. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-46526-5_10 · Cited by 6
Calcium and redox homeostasis in Alzheimer's disease: a focus on the endoplasmic reticulum
(2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.428 · Cited by 5
Cited by
Current state of Alzheimer’s fluid biomarkers
Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., Fagan, A. M., Hampel, H., Mielke, M. M., Mikulskis, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1932-x · Cited by 518
Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
Stanciu, G. D., Luca, A., Rusu, R. N., Bild, V., Beschea Chiriac, S. I., Solcan, C., Bild, W., & Ababei, D. C. (2019) · Biomolecules · doi:10.3390/biom10010040 · Cited by 297
Fan, S., Zheng, Y., Liu, X., Fang, W., Chen, X., Liao, W., Jing, X., Lei, M., Tao, E., Ma, Q., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461955 · Cited by 258
Jabir, N. R., Khan, F. R., & Tabrez, S. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12971 · Cited by 187
López-Ortiz, S., Valenzuela, P. L., Seisdedos, M. M., Morales, J. S., Vega, T., Castillo-García, A., Nisticò, R., Mercuri, N. B., Lista, S., Lucia, A., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101479 · Cited by 152
Metadata
- Authors
- Sanabria-Castro, A., Alvarado-Echeverría, I., & Monge-Bonilla, C.
- Venue
- Annals of Neurosciences
- Publisher
- SAGE Publications
- Published
- 2017
- Volume
- 24
- Issue
- 1
- Pages
- 46-54
- ISSN
- 0972-7531 (ISSN-L)
- 0976-3260
- OpenAlex
- W2610300115
- Cited by
- 418
- References
- 104
- FWCI
- 27.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.